Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Eli Lilly

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Indianapolis, Indiana, United States Founded 1876 10001+ employees For Profit
Website LinkedIn Twitter

Eli Lilly is a pharma company focused on developing medicines for diabetes, cancer, immunology, and other major health areas.

Eli Lilly on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

BiotechnologyHealth CareMedicalPharmaceutical
Total Funding
$6.5B
Funding Rounds
1
Last Funding
Acquisitions
51
Investments
137
34 exits
Monthly Visits
Contacts
9,017
Ticker
LLY
NYSE - New York Stock Exchange
Patents
1,970
1,122 trademarks

About Eli Lilly

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
LLY
Exchange
NYSE - New York Stock Exchange
IPO date
Jan 13, 1978

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
16
Mobile apps
1
Active products
32
Patents granted
1,970
Trademarks
1,122
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$1.41B

Investor Activity

Investments
137
Lead investments
33
Portfolio orgs
115
Diversity investments
29
Exits
34
Exits via IPO
20

Company Info

Founded
1876
Employees
10001+
Operating status
Active
Company type
For Profit
Org types
company, investor
Founders
1
Sub-organizations
12
News articles
9,618
Events
3
HQ
Indianapolis, Indiana, United States
Region
Great Lakes, Midwestern US
Exit date
Jan 13, 1978

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
-0.6
Trend (30d)
1.6
Trend (90d)
5.9
Last leadership hire
Feb 4, 2026
Last layoff mention
Jun 4, 2026

Eli Lilly Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–1 of 1Show
Page 1 / 1

Eli Lilly Investments

Loading columns…
0 of 0Show
Page 1 / 1

Eli Lilly Acquisitions

54 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Sangamo Therapeutics$50M2026-09-04Eli LillyacquisitionCashBiotechnologyGeneticsHealth CarePharmaceuticalTherapeuticsRichmondUnited StatesSangamo researches, develops and commercializes engineered D…1995-01-01251-500BiotechnologyHealth CareMedicalPharmaceuticalUnited States10001+Public51www.sangamo.com
Merida Biosciences$2.87B2026-08-31Eli LillyacquisitionCashBiotechnologyLife ScienceTherapeuticsCambridgeUnited StatesMerida Biosciences is a biotech company focused on developin…2022-01-0111-50BiotechnologyHealth CareMedicalPharmaceuticalUnited States10001+Public51meridabio.com
AtaiBeckley$3.8B2026-07-16Eli Lillyacquisition—BiotechnologyLife ScienceMental HealthNeuroscienceTherapeuticsBerlinGermanyAtaiBeckley develops innovative mental health treatments tha…——BiotechnologyHealth CareMedicalPharmaceuticalUnited States10001+Public51www.ataibeckley.com
4E Therapeutics—2026-06-16Eli LillyAcquisition—BiotechnologyHealth CarePharmaceuticalTherapeuticsAustinUnited States4E Therapeutics is a neuroscience company that develops ther…2019-01-0111-50BiotechnologyHealth CareMedicalPharmaceuticalUnited States10001+Public514etherapeutics.com
Curevo$1.5B2026-05-26Eli LillyAcquisitionCashBiopharmaBiotechnologyHealth CareMedicalBothellUnited StatesCurevo is a clinical-stage biotechnology company developing …2018-01-0111-50BiotechnologyHealth CareMedicalPharmaceuticalUnited States10001+Public51www.curevovaccine.com
1–5 of 54Show
Page 1 / 11

Eli Lilly Key People

Chief Executive Officer
Principal Research Scientist
Director
Chief Scientific and Product Officer and President
IT Collaboration Capabilities Architect
Medical Fellow, Clinical Lead
Senior Advisor, Consumer Marketing
Material Management Technical Support
Executive Director, Business Development
President, International
Manager LRL Medicine Development IT - Regulatory Affairs & Patient Safety
Associate Director - Medical Device Development Quality Assurance
Sr. Vice President and General Manager
TS/MS Consultant, External Manufacturing, Americas
Senior Director, Oncology Communications
Wholesale Drug Distributor Licensing Consultant
Bioprocess Chemist
Bioprocess Chemist
Senior Vice President and Chief AI Officer
Senior Vice President, Global Quality
Vice President Global Marketing
SVP, Human Resources, and Diversity
Senior Director Procurement, Global Research & Development
Distinguished Research Fellow
9,017
professional contacts at Eli Lilly
Contact execs at Eli Lilly →

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Eli Lilly

Loading news…

FAQs about Eli Lilly

People who checked this page also checked these

Sectors Eli Lilly invests & acquires in

BiotechnologyHealth CareTherapeuticsMedicalPharmaceutical

M&A by year

202620252024202320222021
Browse the full Acquirezy directory.